tiprankstipranks
Trending News
More News >
Buy Rating for Oric Pharmaceuticals: Promising Pipeline and Strong Financial Position
PremiumRatingsBuy Rating for Oric Pharmaceuticals: Promising Pipeline and Strong Financial Position
6d ago
Oric Pharmaceuticals reports Q1 EPS (42c), consensus (50c)
Premium
The Fly
Oric Pharmaceuticals reports Q1 EPS (42c), consensus (50c)
7d ago
Oric Pharmaceuticals presents preclinical ORIC-944 data at AACR
Premium
The Fly
Oric Pharmaceuticals presents preclinical ORIC-944 data at AACR
14d ago
Positive Growth Outlook for Oric Pharmaceuticals Driven by Clinical Catalysts and Financial Stability
PremiumRatingsPositive Growth Outlook for Oric Pharmaceuticals Driven by Clinical Catalysts and Financial Stability
3M ago
Oric Pharmaceuticals reports Q4 EPS (51c), consensus (51c)
Premium
The Fly
Oric Pharmaceuticals reports Q4 EPS (51c), consensus (51c)
3M ago
Oric Pharmaceuticals announces upcoming milestones
Premium
The Fly
Oric Pharmaceuticals announces upcoming milestones
3M ago
Oric Pharmaceuticals: Promising Trials and Strong Financials Justify Buy Rating
PremiumRatingsOric Pharmaceuticals: Promising Trials and Strong Financials Justify Buy Rating
3M ago
Cantor says Oric accidental release looks ‘very positive’ for mevrometostat
Premium
The Fly
Cantor says Oric accidental release looks ‘very positive’ for mevrometostat
3M ago
Optimistic Buy Rating for Oric Pharmaceuticals Driven by Promising Data and Favorable Risk/Reward Profile
Premium
Ratings
Optimistic Buy Rating for Oric Pharmaceuticals Driven by Promising Data and Favorable Risk/Reward Profile
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100